GlassScriptPhysician profile
Mark L Miedema
NPI 1205063211
$34,951.76
in general payments reported to CMS, 2019-2025
31 companies · $6,081 in 2025
The $6,081 reported for 2025 was more than what 95% of Pain Medicine (Physical Medicine & Rehabilitation) providers received nationally (typical 2025 total: $400).
See the full distribution for Pain Medicine (Physical Medicine & Rehabilitation)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $9,587 · 2020: $2,061 · 2021: $5,147 · 2022: $2,196 · 2023: $7,144 · 2024: $2,735 · 2025: $6,081.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $9,113 · Food and Beverage: $5,735 · Travel and Lodging: $1,093 · Education: $19.57.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $9,112.62 |
| Food and Beverage | $5,734.87 |
| Travel and Lodging | $1,093.42 |
| Education | $19.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $14,704.75 | 2019-2025 | Proclaim, Eterna, Octrode |
| Amniox Medical, INC. | $8,581.88 | 2019-2020 | |
| Biotissue Holdings INC. | $6,936.61 | 2019-2025 | |
| Boston Scientific Corporation | $1,550.02 | 2019-2024 | Wavewriter Alpha Prime 16 |
| Medtronic, INC. | $1,047.65 | 2021-2025 | Inceptiv, Intellis Adaptivestim, Synchromedii |
| Saluda Medical Americas, INC. | $897.02 | 2024-2025 | Evoke |
| Nevro Corp. | $424.80 | 2019-2023 | Senza |
| Becton, Dickinson and Company | $120.44 | 2022 | |
| Globus Medical, INC. | $71.87 | 2025 | Senza, Vyrsa V1 |
| Medtronic USA, INC. | $68.65 | 2019-2020 | |
| Stryker Corporation | $60.16 | 2025 | Mild Device Kit |
| Spr Therapeutics, INC | $43.87 | 2022-2024 | Sprint Pns System |
| Abbvie INC. | $42.23 | 2022 | |
| Pacira Therapeutics, INC. | $39.25 | 2020 | |
| Innovation Technologies INC | $38.38 | 2023 | Irrisept |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Djo, LLC | $28.81 | 2024 | Cmf |
| Vertiflex, INC. | $28.15 | 2019 | |
| Kci USA, INC. | $26.74 | 2021-2023 | Prevena |
| Nalu Medical, INC. | $24.85 | 2022 | |
| Baudax Bio INC. | $24.69 | 2022 | |
| Horizon Therapeutics Plc | $23.20 | 2020-2021 | |
| Ani Pharmaceuticals, INC. | $20.88 | 2025 | Purified Cortrophin Gel |
| Polynovo North America LLC | $18.67 | 2023 | |
| Pacira Pharmaceuticals Incorporated | $18.63 | 2021 | |
| Si-Bone, INC. | $18.13 | 2024 | |
| Averitas Pharma INC. | $17.77 | 2025 | Qutenza |
| Arbor Pharmaceuticals, INC. | $17.41 | 2019 | |
| Painteq LLC | $17.05 | 2022 | |
| Midsouth Orthopedics INC. | $15.52 | 2023 | |
| Acell, INC. | $11.98 | 2019 | |
| Pfizer INC. | $11.70 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Miedema listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.